# Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)

> **NCT00212771** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 440 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** asenapine
- **DRUG:** olanzapine

## Key facts

- **NCT ID:** NCT00212771
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-10
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2022-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00212771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00212771, "Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00212771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*